Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An osmotic agent in the context of the peritoneum refers to a solute, most commonly glucose, that is introduced into the peritoneal cavity during peritoneal dialysis (PD) to create an osmotic gradient across the peritoneal membrane. This gradient drives ultrafiltration—the movement of water from blood vessels in the peritoneum into the dialysate—by osmosis. Other osmotic agents like icodextrin or amino acids can also be used. The effectiveness depends on agent concentration, membrane permeability, and the reflection coefficient.
Creates crystalloid osmotic pressure gradient to drive ultrafiltration
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osmotic Agent (Peritoneum).